Friedreich Ataxia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You took the medication omaveloxolone (for Friedreich's ataxia) at any point during pregnancy — including up to 12 days before becoming pregnant — or at any point while breastfeeding (until your baby is 1 year old or you stop breastfeeding, whichever happens first)
Who may not be able to join:
- You did not take omaveloxolone for Friedreich's ataxia during pregnancy or while breastfeeding
Important: There may be additional eligibility requirements not listed here. Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Medical Director, Biogen
Phone: 866-633-4636
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Major Congenital Malformations (MCMs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.